Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,429 public trials 1,038 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia.

NCT01641107

Conditions
Acute Lymphoblastic Leukemia, BCR-ABL Positive, Hematologic Diseases, +11 more
Locations
  • S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI Ancona, Italy
  • Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli Piceno, Italy
  • Az.Ospedaliera S.G.Moscati Avellino, Italy
View all 42 locations
View Trial Details
Completed

Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy

NCT01404949

Conditions
Acute Promyelocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Northwestern University Evanston, Illinois, United States
  • National Heart, Lung, and Blood Institute (NIH) Bethesda, Maryland, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
View Trial Details
Completed

Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies

NCT02120157

Conditions
Bone Marrow Diseases, Graft Survival, HLA-mismatched Bone Marrow Transplantation, +17 more
Locations
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • Nemours Alfred I. DuPont Hospital for Children Wilmington, Delaware, United States
  • All Children's Hospital Johns Hopkins Medicine St. Petersburg, Florida, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Completed

Pasireotide in Prevention of GI Toxicity

NCT02215070

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +22 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation

NCT00375219

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Teva Investigational Site 003 Los Angeles, California, United States
  • Teva Investigational Site 007 Jacksonville, Florida, United States
  • Teva Investigational Site 006 Atlanta, Georgia, United States
  • Teva Investigational Site 008 Beech Grove, Indiana, United States
View all 32 locations
View Trial Details
Completed

Treatment of Patients With Myelodysplastic Syndrome or Acute Myelocytic Leukemia With an Impending Hematological Relapse With Azacitidine (Vidaza)

NCT01462578

Conditions
Acute Myelocytic Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Charité Campus Benjamin Franklin Berlin, Germany
  • Universitätsklinikum Bonn Bonn, Germany
  • Klinikum Chemnitz (Küchwald) Chemnitz, Germany
  • Universitätsklinikum Carl Gustav Carus, Medizinische Klinik und Poliklinik I Dresden, Germany
View Trial Details

Related conditions